Literature DB >> 22454895

Availability of methaqualone from commercial preparations: in vitro and in vivo studies in man.

M E Williams1, M J Kendall, M Mitchard, S S Davis, R Poxon.   

Abstract

1 The plasma profiles of methaqualone obtained from different commercially available preparations have been compared. Tablets were absorbed more efficiently than capsules. Mandrax preparations achieved much higher plasma levels than Melsedin tablets or the Melsed or Sedaquin capsules. These differences appear to be due to formulation factors. 2 The efficacy of the different drugs as hypnotics corresponded well with the blood levels achieved. 3 There was a significant correlation between the in vitro l/t(50%) and the in vivo peak plasma levels. Thus in vitro dissolution studies can be used to predict the efficiency of absorption of different formulations in man.

Entities:  

Year:  1974        PMID: 22454895      PMCID: PMC1402450          DOI: 10.1111/j.1365-2125.1974.tb00217.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Prescribing mandrax.

Authors:  H Matthew
Journal:  Br Med J       Date:  1973-05-12

2.  An improved quantitative gas-liquid chromatographic assay for the estimation of methaqualone in biological fluids.

Authors:  M Mitchard; M E Williams
Journal:  J Chromatogr       Date:  1972-10-05

3.  A comparison of the hypnotic properties of mandrax and its two constituents.

Authors:  J Beaubien; F E Kristof; H E Lehmann; T A Ban
Journal:  Curr Ther Res Clin Exp       Date:  1968-05

4.  Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules.

Authors:  J G Wagner
Journal:  J Pharm Sci       Date:  1969-10       Impact factor: 3.534

5.  Hazard of therapeutic nonequivalency of drug products.

Authors:  G H Schneller
Journal:  J Am Pharm Assoc       Date:  1969-09       Impact factor: 2.217

6.  The biopharmaceutical properties of solid dosage forms. I. An evaluation of 23 brands of phenylbutazone tablets.

Authors:  R O Searl; M Pernarowski
Journal:  Can Med Assoc J       Date:  1967-06-10       Impact factor: 8.262

7.  Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms.

Authors:  M Gibaldi; S Feldman
Journal:  J Pharm Sci       Date:  1967-10       Impact factor: 3.534

  7 in total
  2 in total

1.  Serum concentrations of methaqualone after repeated oral doses of a combination formulation to human subjects.

Authors:  C White; E Doyle; L F Chasseaud; T Taylor
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics of hypnotics.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.